139 related articles for article (PubMed ID: 31519500)
1. Reappraisal of giant basal cell carcinoma: Clinical features and outcomes.
Oudit D; Pham H; Grecu T; Hodgson C; Grant ME; Rashed AA; Allan D; Green AC
J Plast Reconstr Aesthet Surg; 2020 Jan; 73(1):53-57. PubMed ID: 31519500
[TBL] [Abstract][Full Text] [Related]
2. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
3. When basal cell carcinomas became giant: an Italian multicenter study.
Gualdi G; Monari P; Calzavara-Pinton P; Caravello S; Fantini F; Bornacina C; Specchio F; Argenziano G; Simonetti V; Caccavale S; La Montagna M; Cecchi R; Landi C; Simonacci M; Dusi D; Puviani M; Zucchi A; Zampieri P; Inchaurraga MAG; Savoia F; Melandri D; Capo A; Amerio P
Int J Dermatol; 2020 Mar; 59(3):377-382. PubMed ID: 31774173
[TBL] [Abstract][Full Text] [Related]
4. Sequential treatment of giant basal cell carcinomas.
Madan V; West CA; Murphy JV; Lear JT
J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
[TBL] [Abstract][Full Text] [Related]
5. Giant Basal Cell Carcinomas Express Neuroactive Mediators and Show a High Growth Rate: A Case-Control Study and Meta-Analysis of Etiopathogenic and Prognostic Factors.
Yazdani Abyaneh MA; Engel P; Slominski A; Ragsdale B; Agag R; Cramer D; Carlson JA
Am J Dermatopathol; 2017 Mar; 39(3):189-194. PubMed ID: 27759693
[TBL] [Abstract][Full Text] [Related]
6. [Why is it important to differentiate trichoblastic carcinomas (CT) from basal cell carcinomas (CBC). About 21 cases].
Thomas M; Bruant-Rodier C; Bodin F; Cribier B; Huther M; Dissaux C
Ann Chir Plast Esthet; 2017 Jun; 62(3):212-218. PubMed ID: 28385570
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for local recurrence of basal cell carcinoma and cutaneous squamous cell carcinoma of the middle third of the face: a 15-year retrospective analysis based on a single centre.
Bourlidou E; Vahtsevanos K; Kyrgidis A; Tilaveridis I; Patsatsi A; Andreadis D; Cheva A; Patrikidou A; Kitikidou K; Boboridis K
Eur J Dermatol; 2019 Oct; 29(5):490-499. PubMed ID: 31789273
[TBL] [Abstract][Full Text] [Related]
8. Comparison of treatment modalities for recurrent basal cell carcinoma.
Sakura CY; Calamel PM
Plast Reconstr Surg; 1979 Apr; 63(4):492-6. PubMed ID: 424458
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
Kiely JR; Patel AJK
J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
[TBL] [Abstract][Full Text] [Related]
10. Treatment of giant basal cell carcinomas of the head and neck with aggressive resection and complex reconstruction.
Arslan H; Güzel MZ; Cnar C
J Craniofac Surg; 2012 Nov; 23(6):1634-7. PubMed ID: 23147292
[TBL] [Abstract][Full Text] [Related]
11. Giant Basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature.
Archontaki M; Stavrianos SD; Korkolis DP; Arnogiannaki N; Vassiliadis V; Liapakis IE; Christ H; Rapidis AD; Kokkalis G
Anticancer Res; 2009 Jul; 29(7):2655-63. PubMed ID: 19596942
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
Armstrong LTD; Magnusson MR; Guppy MPB
J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
[TBL] [Abstract][Full Text] [Related]
13. Giant basal cell carcinoma of the forehead: a case report.
Rudić M; Kranjcec Z; Lisica-Sikić N; Kovacić M
Coll Antropol; 2012 Mar; 36(1):317-9. PubMed ID: 22816239
[TBL] [Abstract][Full Text] [Related]
14. Ocular preservation through limited tumor excision combined with ALA-PDT in patients with periocular basal cell carcinoma.
Li X; Tan L; Kou H; Zhang J; Wang Y; Li G; Lu Y
Photodiagnosis Photodyn Ther; 2019 Sep; 27():291-294. PubMed ID: 31233885
[TBL] [Abstract][Full Text] [Related]
15. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy.
Mougel F; Debarbieux S; Ronger-Savlé S; Dalle S; Thomas L
Dermatology; 2009; 219(2):138-42. PubMed ID: 19590166
[TBL] [Abstract][Full Text] [Related]
16. Do basal cell carcinomas recur after complete conventional surgical excision?
Griffiths RW; Suvarna SK; Stone J
Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy in the management of basal cell carcinoma: Retrospective evaluation of outcome.
Jerjes W; Hamdoon Z; Hopper C
Photodiagnosis Photodyn Ther; 2017 Sep; 19():22-27. PubMed ID: 28442314
[TBL] [Abstract][Full Text] [Related]
18. Combined CO(2) laser with photodynamic therapy for the treatment of nodular basal cell carcinomas.
Whitaker IS; Shokrollahi K; James W; Mishra A; Lohana P; Murison MC
Ann Plast Surg; 2007 Nov; 59(5):484-8. PubMed ID: 17992139
[TBL] [Abstract][Full Text] [Related]
19. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinomas treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage.
Soler AM; Warloe T; Berner A; Giercksky KE
Br J Dermatol; 2001 Sep; 145(3):467-71. PubMed ID: 11531838
[TBL] [Abstract][Full Text] [Related]
20. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
